Press Release ENHERTU® Followed by THP Supplemental Biologics License Application Accepted in the U.S. for Patients with High-Risk HER2 Positive Early-Stage Breast Cancer Prior to Surgery 1 October 2025
Press Release Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease 1 October 2025
Press Release Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30 1 October 2025
Press Release Justin Condreay Joins Academy Securities as Managing Director, Head of Equity Capital Markets 1 October 2025
Press Release Nextdoor’s 13th Annual Treat Map Returns to Help Neighbors Uncover Local Halloween Gems 1 October 2025
